Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS

Guest: Michael Levy, MD, PhD Antibody-mediated demyelinating diseases, such as neuromyelitis optica spectrum disorder and MOG antibody disease, differ fundamentally from multiple sclerosis (MS) due to their association with specific antibodies. Dr. Michael Levy explains how these conditions progress, how relapses can drive disability, and why prevention is critical for improving long-term outcomes. Dr. Levy is an Associate Professor at Harvard Medical School working in the Department of Neurology at Brigham and Women's Hospital, and he spoke about this topic at the 2025 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress.

You can listen to Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS online on Radio and Podcast. Open the player on this page to stream the available audio.

Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS is an episode from NeuroFrontiers by ReachMD.

This episode is 00:04:45 long.

This episode was published on Sep 29, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from NeuroFrontiers when more episodes are available from the podcast feed.